Interleukin-18 levels in adult dengue fever and dengue hemorrhagic fever

Herdiman T. Pohan; Suhendro Suhendro; Rika Bur; Asnath Matondang; Samsuridjal Djauzi; Katsuya Inada; Shigeatsu Endo

doi:10.13181/mji.v13i2.136

Interleukin-18 levels in adult dengue fever and dengue hemorrhagic fever

Authors

Herdiman T. Pohan
Suhendro Suhendro
Rika Bur
Asnath Matondang
Samsuridjal Djauzi
Katsuya Inada
Shigeatsu Endo

DOI:

https://doi.org/10.13181/mji.v13i2.136

Abstract viewed: 1010 times
PDF downloaded: 527 times

Abstract

Interleukin (IL)-18 ( interferon-Î³ inducing factor) is one of cytokines, produced by macrophage, take part in differentiation T-helper (Th) to Th1 and interferon Î³Â producing. T helper1 play role in cellular immunity especially in viral infection include dengue. A descriptive correlative study has done to know the correlation between IL-18 levels and disease severity in admitted dengue fever (DF) and dengue hemorrhagic fever (DHF) patients. In 42 subjects consist of 20 (47.6%) DF and 22 (53.3%) DHF (grade I to IV WHO criteria, 1999) showed that IL-18 levels significantly higher in DHF than DF patients. There are significant correlation between IL-18 levels and hematocrit and low platelet value. This study supports the possible role of IL-18 in pathogenesis DHF in adults. (Med J Indones 2004; 13: 86-9)

Keywords: dengue, dengue hemorrhagic fever, IL-18, cytokine, pathogenesis

Downloads

Download data is not yet available.

Downloads

Published

2004-05-01

How to Cite

Pohan HT, Suhendro S, Bur R, Matondang A, Djauzi S, Inada K, Endo S. Interleukin-18 levels in adult dengue fever and dengue hemorrhagic fever. Med J Indones [Internet]. 2004May1 [cited 2024Dec.22];13(2):86-9. Available from: https://mji.ui.ac.id/journal/index.php/mji/article/view/136

Download Citation

Issue

Vol. 13 No. 2 (2004): April-June

Section

Clinical Research

License

Authors who publish with Medical Journal of Indonesia agree to the following terms:

Authors retain copyright and grant Medical Journal of Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License that allows others to remix, adapt, build upon the work non-commercially with an acknowledgment of the work’s authorship and initial publication in Medical Journal of Indonesia.
Authors are permitted to copy and redistribute the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Medical Journal of Indonesia.